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News from the cyst: insights into polycystic kidney disease
Abstract
Autosomal recessive and autosomal dominant polycystic kidney disease (ADPKD and ARPKD) are 2
major variants of inherited diseases leading to the cystic degeneration of the kidney and other organs.
Primary cilia have moved into the focus of research as it is becoming increasingly clear that dysfunction
of this special cell organelle represents the main underlying mechanism of disease. At the same time, we
also learn that the primary cilium plays an important role in the regulation of cell proliferation and
transport processes along the nephron in the healthy kidney. Three recent publications implicate 2 novel
players in ciliogenesis and cyst formation: the von Hippel Lindau tumor suppressor gene (pVHL) and
collectrin.
 
 
News from the cyst: insights into polycystic kidney disease 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Carsten A. Wagner 
Institute of Physiology and Zurich Center for Integrative Human Physiology 
University of Zurich 
Winterthurerstrasse 190 
CH-8057 Zurich 
Switzerland 
Phone: +41-44-63 50659 
Fax: +41-44-63-56814 
Email: Wagnerca@access.unizh.ch 
 2
Summary 
 
Autosomal recessive and autosomal dominant polycystic kidney disease 
(ADPKD and ARPKD) are two major variants of inherited diseases leading to the 
cystic degeneration of the kidney and other organs. Primary cilia have moved into the 
focus of research as it is becoming increasingly clear that dysfunction of this special 
cell organelle represents the main underlying mechanism of disease. At the same 
time, we also learn that the primary cilium plays an important role in the regulation of 
cell proliferation and transport processes along the nephron in the healthy kidney. 
Three recent publications implicate two novel players in ciliogenesis and cyst 
formation, the von Hippel Lindau tumor suppressor gene (pVHL) and collectrin.  
 
 
Polycystic kidney disease 
 
Polycystic kidney disease represents one of the major causes of inherited 
conditions leading to end stage renal disease. Autosomal dominant polycystic kidney 
disease (ADPKD) is the third most common single cause for ESRD. Two major forms 
of polycystic disease can be distinguished, an autosomal dominant and an autosomal 
recessive form. Autosomal dominant polycystic kidney disease (ADPKD) occurs with 
an estimated frequency of about 1:400-1:1000 in live births, presents usually only 
during the forth or fifth decade of life,  and is characterized by bilateral renal cysts 
and extrarenal abnormalities such as liver cysts, aortic aneurysms, abdominal wall 
hernias, and mitral valve prolaps (1-4). In contrast, autosomal recessive polycystic 
kidney disease (ARPKD) is much rarer with about 1:20’000 in live births but becomes 
symptomatic much earlier in life with bilateral renal cysts and hepatic fibrosis (1-4). 
Additional inherited disorders are associated with renal cyst formation such as 
autosomal dominant polycystic liver disease (mutations in PRKCSH, SEC63), 
autosomal dominant tuberous sclerosis complex (TSC1 (Hamartin) and TSC2 
(Tuberin)), autosomal dominant von Hippel-Lindau disease (VHL), autosomal 
dominant medullary cystic disease (MCKD1 and MCKD2 (uromodulin)), and 
autosomal recessive Nephronophthisis (NPHP1-6 (including inversin) or in Bardet-
Biedl syndrome (1-4).  
 3
Most cases of ADPKD are due to mutations either in PKD1 (located on chromosome 
16p13.3, 85 % of cases) or PKD2 (chromosome 4q21, around 15 % of cases). The 
proteins formed by PKD1 and PKD2 are polycystin1 and polycystin2, two proteins 
predominantely expressed in the plasma membrane of many cells including many 
epithelial cells of the kidney. The subcellular localization of PKD1 is associated with 
cell-cell contacts such as tight junctions or desmosomes, whereas PKD2 shows a 
high homology to Transient Receptor Potential Channels (TRPC) subunits and 
localizes more to the ciliar body and base. PKD2 appears to form a cation channel 
with high permeability to calcium. ARPKD is caused by mutations in PKHD1 
(Fibrocystin), a protein expressed in primary cilia. 
Much has been learnt about polycystic kidney disease from genetic studies and 
various animal models that develop spontaneous or induced cysts. A common 
feature is that in all instances the mutations affect proteins that form part of the 
primary cilia and/ or centrosome. 
 
 
Primary cilia: sensors and regulators 
 
In kidney all epithelial cells with the exception of intercalated cells possess a 
primary cilium. The biological role of this peculiar cell organelle has long been 
neglected and remained unknown. In 2001 Praetorius and Spring reported that 
bending of cilia increased intracellular calcium and suggested that cilia may function 
as mechanosensors sensing urinary flow and thereby regulate flow-dependent 
changes in renal function (5, 6). Indeed, ciliar function has been subsequently linked 
to cell proliferation, cell death, and flow-dependent changes in cellular functions such 
as sodium absorption and potassium secretion in the collecting duct (7, 8). Thus, the 
polycystin1 and polycystin2 proteins may play an important role in mechanosensation 
as absence of these channel-like proteins reduces Calcium influx upon flow-
dependent ciliar bending.  
The stimulation of cilia dependent intracellular signalling leads to inhibition of 
the canonical Wnt/β-catenin pathway and activates the non-canonical β-catenin/ 
calcium pathway. In non-stimulated cells, β-catenin is degraded by the proteasome 
after phosphorylation by GSK-3β (glycogen synthase kinase 3β). In contrast, 
stimulation of the cilia leads to inversin activation, inhibiting canonical β-catenin 
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signalling, and at the same time PKA and PKC phosphorylate GSK-3β. GSK-
3β inhibition switches to the Wnt/ β-catenin signalling pathway, translocating β-
catenin to the nucleus thereby regulating cell cycle genes.  
 
The von Hippel-Lindau protein and cyst formation 
 
 Schermer et al. and Thoma et al. present now in two independent studies 
evidence for the role of the von Hippel-Lindau protein in a signalling cascade that is 
important in ciliogenesis and maintenance (9, 10). The von Hippel Lindau protein 
(vHL) is best known for its function as a tumor suppressor factor based on its ability 
to target components of the hypoxia induced HIF pathway for degradation (11). Both 
publications demonstrate that the vHL protein is expressed in the cilium of various 
kidney cell lines and in vivo. Deletion of vHL in primary cell cultures does not affect 
cilia expression but sensitizes cells in the presence of growth factors to loose their 
cilia. Apparently growth factors inhibited GSK-3β which otherwise phosphorylates 
and blocks the vHL protein (10). The major function of the vHL protein in this context 
may be the microtubule stabilizing function which is important for ciliar function. 
These results suggested that the vHL protein is required for ciliagenesis when GSK-
3β becomes inactivated and that loss of both active proteins may promote cyst 
formation. Accordingly, in kidneys from vHL patients, phosphorylated and thus 
inactive GSK-3β was detected in cystic regions. A model is proposed in which both 
vHL protein and GSK-3β promote ciliagenesis and maintenance (10). However, GSK-
3β inhibits vHL protein function but is alone sufficient to mediate positive signals to 
the cilium. Under normal conditions, GSK-3β is blocked by upstream unknown 
signals and vHL is responsible for ciliar microtubule regulation. Thus, in vHL disease 
a second event (i.e. a second mutation) must occur phosphorylating or inactivating 
otherwise GSK-3β, thereby removing both maintenance signals from the cilia leading 
to ciliar loss and cyst formation.  
Schermer and colleagues (9) investigated further the mechanism by which the 
vHL protein affects cilia integrity and found the vHL protein to be associated with the 
β-tubulin microtubular protein. In contrast to Thoma et al, they did however not find 
evidence for a microtubule stabilizing effect of the vHL protein. Interestingly, the vHL 
protein appears to play a role in the coordination of directed microtubular growth 
which may contribute to ciliagenesis. Moreover, an interaction was found with a 
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signalling complex consisting of Par3-Par6-atypical protein kinase C which localizes 
to the cilia and may regulate microtubular functions. Collectively, both papers 
demonstrate that the vHL protein is expressed in the cilium and is involved in the 
regulation of the microtubular network. Thus, the vHL is a novel partner of the 
signalling network controlling ciliagenesis and maintenance and its loss may 
contribute to renal cyst formation. 
 
 
A novel protein in ciliar dysfunction: collectrin 
 
A recent study by Zhang et al implies collectrin as a new player in cilia 
formation and cell polarity of collecting duct cells (12). Collectrin is a membrane 
protein which shows high homology to the angiotensin II converting enzyme 2 
(ACE2) but lacks the catalytic domain required for angiotensin II degradation. Initially 
described as a protein of unknown function expressed in renal collecting ducts 
(hence the name “collectrin”), it was later shown in knock-out mouse models to be 
expressed highly in the brush border membrane of the proximal tubule. There 
collectrin is associated with several amino acid transporters and is critical for their 
expression. Lack of collectrin causes massive amino acid losses in urine (13).  In 
addition, studies by Akpinar et al. and Fukui and colleagues suggested an important 
role of collectrin in pancreatic beta cell proliferation and insulin secretion based on in 
vitro experiments in transfected cell lines and transgenic mice overexpressing 
collectrin in beta cells (14, 15).  
Zhang et al now uses an inner medullary collecting duct cell line, report localization of 
collectrin in the central cilia, and demonstrate alterations in ciliar ultrastructure after 
knock-down of collectrin.  Interactions between collectrin and several ciliar proteins 
such as polycystin 2 are reported. These data suggest that collectrin is important for 
normal cilia formation and that loss of functional collectrin may be linked to cyst 
formation. Therefore, knock-down of collectrin in mouse metanephric organ cell 
culture systems was performed and multiple cysts were observed. At this point it may 
be tempting to speculate that collectrin is a novel protein involved in ciliogenesis and 
that its dysfunction may be linked to cystic kidney disease. However, collectrin is an 
X chromosomal gene and no evidence has been obtained so far to demonstrate an 
X-linked form of polycystic kidney disease. Moreover, it should also be noted that in 
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collectrin deficient mice no abnormalities in renal morphology were observed 
(Danilcyzk, Penninger, Verrey, Wagner, unpublished observations). These two 
observations are in striking contrast to the data obtained in cell culture models and 
will require further work to resolve this problem. 
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